A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection

Table 5

Survival or need for mechanical ventilation in comprehensive analysis colchicine and control groups. Hospitalization days were nonnormally distributed. The Mann–Whitney U test was used to check for differences in the two groups. The χ² test was used to check for differences in the number of intubations, patients expired, and patients intubated in the two groups and mortality in intubated patients.

	Colchicine group (N = 34)	Control group (N = 78)	value
Hospitalization days (median)	10.5	11	0.947
Discharged (percentage)	18 (52.9)	15 (19.2)	0.0003
Expired (percentage)	16 (47.1)	63 (80.8)	0.0003
Intubated (percentage)	16 (47.1)	68 (87.2)	<0.0001
Mortality in intubated patients (percentage)	15/16 (93.8)	60/68 (88.2)	0.455